Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), by Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & Marketing, Drug Safety), End User (Pharma, Medical Device) & Region - Global Forecast to 2030

1 INTRODUCTION 37 1.1 STUDY OBJECTIVES 37 1.2 MARKET DEFINITION 37 1.3 STUDY SCOPE 38 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 38 1.3.2 INCLUSIONS & EXCLUSIONS 39 1.3.3 YEARS CONSIDERED 39 1.3.4 CURRENCY CONSIDERED 40 1.4 STAKEHOLDERS 40 1.5 SUMMARY OF CHANGES 41 2 RESEARCH METHODOLOGY 42 2.1 RESEARCH DATA 42 2.1.1 SECONDARY DATA 42 2.1.1.1 Key data from secondary sources 43 2.1.2 PRIMARY DATA 44 2.1.2.1 Key industry insights 45 2.2 MARKET SIZE ESTIMATION 46 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51 2.4 MARKET SHARE ESTIMATION 52 2.5 RESEARCH ASSUMPTIONS 52 2.6 RESEARCH LIMITATIONS 52 2.6.1 METHODOLOGY-RELATED LIMITATIONS 52 2.6.2 SCOPE-RELATED LIMITATIONS 52 2.7 RISK ANALYSIS 53 3 EXECUTIVE SUMMARY 54 4 PREMIUM INSIGHTS 58 4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW 58 4.2 LIFE SCIENCE ANALYTICS MARKET, BY REGION 59 4.3 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER AND COUNTRY 60 4.4 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT 61 4.5 LIFE SCIENCE ANALYTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 61 5 MARKET OVERVIEW 62 5.1 INTRODUCTION 62 5.2 MARKET DYNAMICS 62 5.2.1 DRIVERS 63 5.2.1.1 Rising pressure to curb healthcare spending 63 5.2.1.2 Need for improved data standardization 64 5.2.1.3 Technological advancements in analytical solutions 65 5.2.1.4 Heterogeneity and complexity of big data in life sciences 66 5.2.1.5 Growing adoption of analytical solutions in clinical trials 67 5.2.1.6 Increasing R&D expenditure in pharmaceutical & biotechnology companies 68 5.2.2 RESTRAINTS 69 5.2.2.1 High implementation costs of advanced analytical solutions 69 5.2.2.2 Data privacy concerns 69 5.2.3 OPPORTUNITIES 71 5.2.3.1 Growing focus on value-based care 71 5.2.3.2 Use of analytics in precision & personalized medicine 71 5.2.3.3 Big data analytics for R&D productivity 72 5.2.3.4 Growing adoption of cloud-based analytics 73 5.2.4 CHALLENGES 73 5.2.4.1 Issues associated with data integration 73 5.2.4.2 Shortage of skilled personnel 74 5.2.4.3 Reluctance to adopt life science analytics solutions in emerging countries 74 5.3 INDUSTRY TRENDS 75 5.3.1 GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS 75 5.3.2 LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG DISCOVERY & DEVELOPMENT 76 5.3.3 FOCUS ON REAL-TIME DATA ANALYTICS 76 5.4 TECHNOLOGY ANALYSIS 77 5.4.1 KEY TECHNOLOGIES 77 5.4.1.1 Artificial intelligence and machine learning 77 5.4.1.2 Big data analytics 77 5.4.1.3 Quantum computing 78 5.4.2 COMPLEMENTARY TECHNOLOGIES 78 5.4.2.1 Bioinformatics tools 78 5.4.2.2 Internet of Things 78 5.4.3 ADJACENT TECHNOLOGIES 79 5.4.3.1 Blockchain 79 5.5 ECOSYSTEM ANALYSIS 79 5.6 VALUE CHAIN ANALYSIS 82 5.7 PORTER’S FIVE FORCES ANALYSIS 83 5.7.1 THREAT OF NEW ENTRANTS 84 5.7.2 THREAT OF SUBSTITUTES 84 5.7.3 BARGAINING POWER OF SUPPLIERS 84 5.7.4 BARGAINING POWER OF BUYERS 85 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 85 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 85 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 85 5.8.2 BUYING CRITERIA 87 5.9 CASE STUDY ANALYSIS 88 5.9.1 NOVARTIS USES MULTI-CLOUD DATA ANALYTICS PLATFORM TO OPTIMIZE OPERATIONS AND ACCELERATE INNOVATION 88 5.9.2 SAS VISUAL ANALYTICS HELPS MAXIMIZE PROFITABILITY THROUGH PRESCRIPTIVE ANALYTICS & DATA VISUALIZATION 89 5.9.3 STREAMLINING REGULATORY MONITORING AND IMPACT ASSESSMENTS: GEDEON RICHTER’S PARTNERSHIP WITH CLARIVATE 89 5.10 REGULATORY LANDSCAPE 90 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 5.10.2 NORTH AMERICA 93 5.10.3 EUROPE 93 5.10.4 ASIA PACIFIC 94 5.10.5 MIDDLE EAST & AFRICA 94 5.10.6 LATIN AMERICA 95 5.11 PRICING ANALYSIS 95 5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION 96 5.11.2 AVERAGE SELLING PRICE, BY REGION 96 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 97 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 98 5.14 PATENT ANALYSIS 98 5.14.1 PATENT PUBLICATION TRENDS 98 5.14.2 JURISDICTION ANALYSIS: TOP APPLICANT 99 5.14.3 MAJOR PATENTS 100 5.15 END USER ANALYSIS 102 5.15.1 UNMET NEEDS 102 5.15.2 END-USER EXPECTATIONS 103 5.16 LIFE SCIENCE ANALYTICS BUSINESS MODELS 104 5.16.1 SUBSCRIPTION-BASED MODEL 104 5.16.2 SAAS MODEL 105 5.16.3 PAY-PER-USE/USAGE-BASED MODEL 105 5.16.4 ENTERPRISE LICENSING 105 5.16.5 FREEMIUM MODEL 105 5.16.6 ENTERPRISE LICENSING 105 5.16.7 CONCURRENT LICENSING 105 5.16.8 CONSULTING SERVICES MODEL 105 5.16.9 PARTNERSHIP/REVENUE-SHARING MODEL 105 5.16.10 HYBRID MODELS 106 5.17 INVESTMENT & FUNDING SCENARIO 106 5.18 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET 108 5.18.1 TOP USE CASES & MARKET POTENTIAL 108 5.18.1.1 Key use cases 110 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 111 5.18.2.1 Case study 1: Knowledge mining for a global biopharmaceutical company 111 5.18.2.2 Healthcare analytics market 112 5.18.3 USER READINESS AND IMPACT ASSESSMENT 113 5.18.3.1 User readiness 113 5.18.3.1.1 Pharmaceutical & biotechnology companies 113 5.18.3.1.2 Medical device companies 113 5.18.3.1.3 Research centers 113 5.18.3.1.4 Outsourced life science organizations 113 5.18.3.2 Impact assessment 114 5.18.3.2.1 User A: Pharmaceutical & biotechnology companies 114 5.18.3.2.1.1 Implementation 114 5.18.3.2.1.2 Impact 114 5.18.3.2.2 User B: Medical device companies 115 5.18.3.2.2.1 Implementation 115 5.18.3.2.2.2 Impact 115 5.18.3.2.3 User C: Research institutes 116 5.18.3.2.3.1 Implementation 116 5.18.3.2.3.2 Impact 116 5.18.3.2.4 User D: Outsourced life science organizations 117 5.18.3.2.4.1 Implementation 117 5.18.3.2.4.2 Impact 117 6 IMPACT OF 2025 US TARIFF—OVERVIEW 118 6.1 INTRODUCTION 118 6.2 KEY TARIFF RATES 118 6.3 PRICE IMPACT ANALYSIS 119 6.4 IMPACT ON COUNTRY/REGION 120 6.4.1 US 120 6.4.2 EUROPE 121 6.4.3 ASIA PACIFIC 121 6.5 IMPACT ON END-USE INDUSTRIES 122 7 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 123 7.1 INTRODUCTION 124 7.2 DESCRIPTIVE ANALYTICS 124 7.2.1 ADVANCED VISUAL DATA EXPLORATION AND SUPPORT FOR INNOVATION TO DRIVE DEMAND 124   7.3 PREDICTIVE ANALYTICS 126 7.3.1 SIMULATION DEVELOPMENT FOR PREDICTING FUTURE TRENDS TO PROPEL MARKET GROWTH 126 7.4 PRESCRIPTIVE ANALYTICS 127 7.4.1 REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH 127 8 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 129 8.1 INTRODUCTION 130 8.2 SERVICES 130 8.2.1 MANAGED SERVICES 132 8.2.1.1 Analytical services 133 8.2.1.1.1 Focus on expediting approvals and product launches to drive growth 133 8.2.1.2 Consulting services 134 8.2.1.2.1 Support for R&D, process development, and other workflow processes to drive market 134 8.2.2 PROFESSIONAL SERVICES 136 8.2.2.1 Training & implementation services 137 8.2.2.1.1 Stringent regulations, increasing competition, and need for skill development to propel demand 137 8.2.2.2 Maintenance & support services 138 8.2.2.2.1 Rising complexity of analytical technologies and expanding research needs to support market growth 138 8.2.2.3 Other professional services 139 8.3 SOFTWARE 140 8.3.1 ON-PREMISES 142 8.3.1.1 Provision of multivendor architecture and security benefits to drive market 142 8.3.2 CLOUD-BASED 143 8.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption 143 8.3.3 SAAS-BASED 145 8.3.3.1 Increasing adoption of digital solutions and advantages of cloud-based models to drive growth 145 9 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 147 9.1 INTRODUCTION 148 9.2 RESEARCH & DEVELOPMENT 148 9.2.1 CLINICAL TRIALS 151 9.2.1.1 Laboratory services 153 9.2.1.1.1 Better accuracy, efficiency, and data interpretation to support demand for lab services 153 9.2.1.2 Patient recruitment services 154 9.2.1.2.1 Need for better candidate identification and enrollment forecasting to propel market growth 154 9.2.1.3 Site identification services 155 9.2.1.3.1 Benefits in locating ideal trial sites and interpreting data to support adoption 155 9.2.1.4 Other clinical trial services 156 9.2.1.5 Life science analytics market for clinical trials, by phase 157 9.2.1.6 PHASE I 158 9.2.1.6.1 Strong pipeline of pharmaceutical companies to propel market growth 158 9.2.1.7 PHASE II 159 9.2.1.7.1 Extended duration of phase II studies to create growth opportunities for CROs 159 9.2.1.8 PHASE III 160 9.2.1.8.1 Rising trial expenditure to drive demand for cost-effective clinical research services 160 9.2.2 PRECLINICAL & DRUG DISCOVERY 161 9.2.2.1 Ability to assist researchers in process innovation and decision support to drive adoption 161 9.3 COMMERCIAL ANALYTICS 163 9.3.1 SALES & MARKETING SUPPORT 165 9.3.1.1 Rising analysis of digital marketing effectiveness to drive adoption 165 9.3.2 MARKET ACCESS 166 9.3.2.1 Focus on strategic pricing, reimbursement, and policy changes to support market growth 166 9.3.3 RWE & VALUE EVIDENCE 167 9.3.3.1 Increased data integration, partnerships, and technological to propel use of RWE 167 9.3.4 ENGAGEMENT SERVICES 169 9.3.4.1 Need for better patient engagement, digital advancements, and AI integration to propel market 169 9.4 REGULATORY COMPLIANCE 170 9.4.1 STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION 170 9.5 MANUFACTURING & SUPPLY CHAIN OPTIMIZATION 171 9.5.1 RISING NEED FOR REDUCING LOGISTICS COSTS TO SUPPORT MARKET GROWTH 171 9.6 SAFETY 173 9.6.1 PHARMACOVIGILANCE 174 9.6.1.1 Monitoring of drug trials and medication programs to fuel market uptake 174 9.6.2 MEDICAL DEVICE SAFETY 175 9.6.2.1 Stringent safety standards, rigorous risk assessments, and robust quality control to drive demand 175 9.6.3 DIAGNOSTIC VIGILANCE 176 9.6.3.1 Continuous monitoring, integration of diverse data sources, and ongoing education to enhance accuracy and thoroughness 176 10 LIFE SCIENCE ANALYTICS MARKET, BY END USER 178 10.1 INTRODUCTION 179 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 179 10.2.1 RISING NEED FOR INNOVATIVE THERAPIES TO DRIVE ANALYTICS USAGE IN PRODUCT DEVELOPMENT 179 10.3 MEDICAL DEVICE COMPANIES 181 10.3.1 ADOPTION OF DATA ANALYTICS FOR DEVICE COMMERCIALIZATION TO DRIVE MARKET 181 10.4 RESEARCH CENTERS 182 10.4.1 NEED FOR ANALYZING LARGE VOLUMES OF DATA TO SUPPORT MARKET GROWTH 182 10.5 OUTSOURCED LIFE SCIENCE ORGANIZATIONS 183 10.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET 183 11 LIFE SCIENCE ANALYTICS MARKET, BY REGION 184 11.1 INTRODUCTION 185 11.2 NORTH AMERICA 185 11.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 186 11.2.2 US 192 11.2.2.1 Established economy and increasing R&D expenditure to drive adoption of analytical solutions 192 11.2.3 CANADA 197 11.2.3.1 Rising need for data standardization in life sciences to fuel uptake 197 11.3 EUROPE 202 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 202 11.3.2 GERMANY 208 11.3.2.1 Growing R&D investments by pharmaceutical & biotechnology companies to drive market 208 11.3.3 FRANCE 213 11.3.3.1 Growing government support for adoption of AI & big data analytics to drive market 213 11.3.4 UK 218 11.3.4.1 Rising clinical trial activity to drive uptake of life science analytics solutions 218 11.3.5 ITALY 222 11.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 222 11.3.6 SPAIN 227 11.3.6.1 Surging government investments focusing on personalized medicine to drive growth 227 11.3.7 REST OF EUROPE 232 11.4 ASIA PACIFIC 236 11.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 237 11.4.2 JAPAN 243 11.4.2.1 Growing government support for clinical R&D activities to drive adoption 243 11.4.3 CHINA 248 11.4.3.1 Growth in life science industry to support adoption of solutions 248 11.4.4 INDIA 253 11.4.4.1 Rising R&D expenditure and drug development to support market growth 253 11.4.5 REST OF ASIA PACIFIC 258 11.5 LATIN AMERICA 263 11.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 263 11.5.2 BRAZIL 268 11.5.2.1 Brazil to dominate life science analytics market in Latin America 268 11.5.3 MEXICO 273 11.5.3.1 Growing prominence of startups and rising R&D activity to propel market 273 11.5.4 REST OF LATIN AMERICA 278 11.6 MIDDLE EAST & AFRICA 283 11.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 283 11.6.2 GCC COUNTRIES 289 11.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market 289 11.6.3 REST OF MIDDLE EAST & AFRICA 294 12 COMPETITIVE LANDSCAPE 299 12.1 OVERVIEW 299 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 299 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 300 12.3 REVENUE ANALYSIS 303 12.4 MARKET SHARE ANALYSIS 303 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 305 12.5.1 STARS 305 12.5.2 EMERGING LEADERS 305 12.5.3 PERVASIVE PLAYERS 305 12.5.4 PARTICIPANTS 306 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 307 12.5.5.1 Company footprint 307 12.5.5.2 Region footprint 308 12.5.5.3 Type footprint 309 12.5.5.4 Application footprint 310 12.5.5.5 Component footprint 311 12.5.5.6 End user footprint 312 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 313 12.6.1 PROGRESSIVE COMPANIES 313 12.6.2 RESPONSIVE COMPANIES 313 12.6.3 DYNAMIC COMPANIES 313 12.6.4 STARTING BLOCKS 313 12.6.5 COMPETITIVE BENCHMARKING 315 12.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS 317 12.8 COMPANY VALUATION AND FINANCIAL METRICS 318 12.9 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICAL VENDORS 318 12.10 COMPETITIVE SCENARIO 319 12.10.1 PRODUCT LAUNCHES & ENHANCEMENTS 319 12.10.2 DEALS 320 13 COMPANY PROFILES 323 13.1 KEY PLAYERS 323 13.1.1 ORACLE 323 13.1.1.1 Business overview 323 13.1.1.2 Products & services offered 324 13.1.1.3 Recent developments 326 13.1.1.3.1 Product launches & enhancements 326 13.1.1.3.2 Deals 326 13.1.1.4 MnM view 327 13.1.1.4.1 Key strengths 327 13.1.1.4.2 Strategic choices 328 13.1.1.4.3 Weaknesses & competitive threats 328 13.1.2 MERATIVE 329 13.1.2.1 Business overview 329 13.1.2.2 Products & services offered 329 13.1.2.3 Recent developments 330 13.1.2.3.1 Deals 330 13.1.2.3.2 Other developments 330 13.1.2.4 MnM view 330 13.1.2.4.1 Right to win 330 13.1.2.4.2 Strategic choices 330 13.1.2.4.3 Weaknesses & competitive threats 331 13.1.3 SAS INSTITUTE INC. 332 13.1.3.1 Business overview 332 13.1.3.2 Products & services offered 333 13.1.3.3 Recent developments 333 13.1.3.3.1 Product launches & enhancements 333 13.1.3.3.2 Deals 334 13.1.3.4 MnM view 335 13.1.3.4.1 Right to win 335 13.1.3.4.2 Strategic choices 335 13.1.3.4.3 Weaknesses & competitive threats 335 13.1.4 ACCENTURE 336 13.1.4.1 Business overview 336 13.1.4.2 Products offered 338 13.1.4.3 Recent developments 338 13.1.4.3.1 Product launches & enhancements 338 13.1.4.3.2 Deals 339 13.1.4.3.3 Other developments 339 13.1.4.4 MnM view 340 13.1.4.4.1 Right to win 340 13.1.4.4.2 Strategic choices 340 13.1.4.4.3 Weaknesses & competitive threats 340 13.1.5 IQVIA INC. 341 13.1.5.1 Business overview 341 13.1.5.2 Products & services offered 342 13.1.5.3 Recent developments 344 13.1.5.3.1 Product launches & enhancements 344 13.1.5.3.2 Deals 345 13.1.5.3.3 Other developments 345 13.1.5.4 MnM view 346 13.1.5.4.1 Right to win 346 13.1.5.4.2 Strategic choices 346 13.1.5.4.3 Weaknesses & competitive threats 346 13.1.6 COGNIZANT 347 13.1.6.1 Business overview 347 13.1.6.2 Products & services offered 348 13.1.6.3 Recent developments 350 13.1.6.3.1 Product launches & enhancements 350 13.1.6.3.2 Deals 350 13.1.7 WIPRO 351 13.1.7.1 Business overview 351 13.1.7.2 Products & services offered 353 13.1.7.3 Recent developments 354 13.1.7.3.1 Deals 354 13.1.8 VERADIGM LLC 355 13.1.8.1 Business overview 355 13.1.8.2 Products & services offered 356 13.1.8.3 Recent developments 357 13.1.8.3.1 Product launches & enhancements 357 13.1.8.4 Recent developments 357 13.1.8.4.1 Deals 357 13.1.9 OPTUM, INC. 358 13.1.9.1 Business overview 358 13.1.9.2 Products & services offered 359 13.1.10 MICROSOFT 360 13.1.10.1 Business overview 360 13.1.10.2 Products & services offered 361 13.1.10.3 Recent developments 362 13.1.10.3.1 Product launches & enhancements 362 13.1.10.3.2 Deals 362 13.1.11 MAXISIT 363 13.1.11.1 Business overview 363 13.1.11.2 Products & services offered 363 13.1.11.3 Recent developments 364 13.1.11.3.1 Product launches & enhancements 364 13.1.12 EXLSERVICE HOLDINGS, INC. 365 13.1.12.1 Business overview 365 13.1.12.2 Products & services offered 366 13.1.12.3 Recent developments 367 13.1.12.3.1 Product launches & enhancements 367 13.1.12.3.2 Deals 367 13.1.13 INOVALON 368 13.1.13.1 Business overview 368 13.1.13.2 Products & services offered 369 13.1.13.3 Recent developments 370 13.1.13.3.1 Product launches & enhancements 370 13.1.13.3.2 Deals 370 13.1.14 CITIUSTECH INC. 371 13.1.14.1 Business overview 371 13.1.14.2 Products & services offered 371 13.1.14.3 Recent developments 372 13.1.14.3.1 Product launches & enhancements 372 13.1.14.3.2 Deals 373 13.1.14.3.3 Expansions 373 13.1.15 SAAMA 374 13.1.15.1 Business overview 374 13.1.15.2 Products & services offered 374 13.1.15.3 Recent developments 375 13.1.15.3.1 Product launches & enhancements 375 13.1.15.4 Recent developments 376 13.1.15.4.1 Deals 376 13.1.15.4.2 Other developments 376   13.1.16 AXTRIA 377 13.1.16.1 Business overview 377 13.1.16.2 Products & services offered 377 13.1.16.3 Recent developments 378 13.1.16.3.1 Product launches & enhancements 378 13.1.16.3.2 Deals 378 13.1.16.3.3 Expansions 378 13.1.17 CLARIVATE 379 13.1.17.1 Business overview 379 13.1.17.2 Products & services offered 381 13.1.17.3 Recent developments 382 13.1.17.3.1 Product launches & enhancements 382 13.1.17.3.2 Deals 383 13.1.18 THOUGHTSPHERE 384 13.1.18.1 Business overview 384 13.1.18.2 Products & services offered 385 13.1.19 THOUGHTSPOT INC. 386 13.1.19.1 Business overview 386 13.1.19.2 Products & services offered 386 13.1.19.3 Recent developments 387 13.1.19.3.1 Product launches & enhancements 387 13.1.19.3.2 Deals 387 13.1.20 SALESFORCE, INC. 388 13.1.20.1 Business overview 388 13.1.20.2 Products & services offered 389 13.1.20.3 Recent developments 390 13.1.20.3.1 Product launches & enhancements 390 13.1.20.3.2 Deals 390 13.2 OTHER PLAYERS 391 13.2.1 GOOGLE LLC 391 13.2.2 AMAZON WEB SERVICES, INC. 392 13.2.3 VEEVA SYSTEMS 393 13.2.4 ELSEVIER 394 13.2.5 KOMODO HEALTH, INC. 395 14 APPENDIX 396 14.1 DISCUSSION GUIDE 396 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 401 14.3 CUSTOMIZATION OPTIONS 403 14.4 RELATED REPORTS 403 14.5 AUTHOR DETAILS 404

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 40 TABLE 2 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT 53 TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN AI IN TELEHEALTH & TELEMEDICINE MARKET 63 TABLE 4 PHARMACEUTICAL COMPANIES IMPACTED BY CYBER INCIDENTS, 2024 70 TABLE 5 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM 81 TABLE 6 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES 84 TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%) 86 TABLE 8 KEY BUYING CRITERIA FOR END USERS 87 TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 14 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION 96 TABLE 15 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION 96 TABLE 16 LIFE SCIENCE ANALYTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS 97 TABLE 17 LIST OF PATENTS/PATENT APPLICATIONS 101 TABLE 18 UNMET NEEDS IN LIFE SCIENCE ANALYTICS MARKET 102 TABLE 19 END-USER EXPECTATIONS IN LIFE SCIENCE ANALYTICS MARKET 103 TABLE 20 MAJOR INVESTMENTS IN AI IN LIFE SCIENCE ANALYTICS MARKET 106 TABLE 21 US-ADJUSTED RECIPROCAL TARIFF RATES 118 TABLE 22 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 124 TABLE 23 DESCRIPTIVE ANALYTICS: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 24 PREDICTIVE ANALYTICS: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 25 PRESCRIPTIVE ANALYTICS: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 26 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 130 TABLE 27 LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 131 TABLE 28 LIFE SCIENCE ANALYTICS MARKET FOR SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 29 LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 132 TABLE 30 LIFE SCIENCE ANALYTICS MARKET FOR MANAGED SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 31 LIFE SCIENCE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 32 LIFE SCIENCE ANALYTICS MARKET FOR CONSULTING SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 33 LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 136 TABLE 34 LIFE SCIENCE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 35 LIFE SCIENCE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 36 LIFE SCIENCE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 37 LIFE SCIENCE ANALYTICS MARKET FOR OTHER PROFESSIONAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 38 LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 141 TABLE 39 LIFE SCIENCE ANALYTICS MARKET FOR SOFTWARE, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 40 LIFE SCIENCE ANALYTICS MARKET FOR ON-PREMISES, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 41 LIFE SCIENCE ANALYTICS MARKET FOR CLOUD-BASED, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 42 LIFE SCIENCE ANALYTICS MARKET FOR SAAS-BASED, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 43 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 148 TABLE 44 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS 149 TABLE 45 LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 150 TABLE 46 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 47 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS 151 TABLE 48 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 49 LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 152 TABLE 50 LIFE SCIENCE ANALYTICS MARKET FOR LABORATORY SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 51 LIFE SCIENCE ANALYTICS MARKET FOR PATIENT RECRUITMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR SITE IDENTIFICATION SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 53 LIFE SCIENCE ANALYTICS MARKET FOR OTHER CLINICAL TRIAL SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 54 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 158 TABLE 55 LIFE SCIENCE ANALYTICS MARKET FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 56 LIFE SCIENCE ANALYTICS MARKET FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 57 LIFE SCIENCE ANALYTICS MARKET FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 58 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL & DRUG DISCOVERY SOLUTIONS 162 TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL & DRUG DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 60 LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 164 TABLE 61 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 62 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS 165 TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING SUPPORT, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR MARKET ACCESS, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 65 LIFE SCIENCE ANALYTICS MARKET FOR RWE & VALUE EVIDENCE, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR ENGAGEMENT SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 67 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS 170 TABLE 68 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 69 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE MANUFACTURING & SUPPLY CHAIN OPTIMIZATION SOLUTIONS 172 TABLE 70 LIFE SCIENCE ANALYTICS MARKET FOR MANUFACTURING & SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 71 LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 173 TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 73 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS 174 TABLE 74 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 75 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE SAFETY, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR DIAGNOSTIC VIGILANCE, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 77 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 78 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 80 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 81 LIFE SCIENCE ANALYTICS MARKET FOR OUTSOURCED LIFE SCIENCE ORGANIZATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 82 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 83 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 84 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 85 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 188 TABLE 86 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 188 TABLE 87 NORTH AMERICA: MANAGED SERVICES MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 189 TABLE 88 NORTH AMERICA: PROFESSIONAL SERVICES MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 189 TABLE 89 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 189 TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 190 TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 190 TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 190 TABLE 93 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 191 TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 191 TABLE 95 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 191 TABLE 96 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 97 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 98 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 193 TABLE 99 US: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 193 TABLE 100 US: MANAGED SERVICES MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 194 TABLE 101 US: PROFESSIONAL SERVICES MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 194 TABLE 102 US: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 194 TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 195 TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 195 TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 195 TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 196 TABLE 107 US: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 196 TABLE 108 US: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 196 TABLE 109 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 110 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 111 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 198 TABLE 112 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICES TYPE, 2023–2030 (USD MILLION) 198 TABLE 113 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 199 TABLE 114 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 199 TABLE 115 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 199 TABLE 116 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 200 TABLE 117 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 200 TABLE 118 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 200 TABLE 119 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 201 TABLE 120 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 201 TABLE 121 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 201 TABLE 122 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 202 TABLE 123 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 124 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 125 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 204 TABLE 126 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 204 TABLE 127 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 204 TABLE 128 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 205 TABLE 129 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 205 TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 205 TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 206 TABLE 132 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 206 TABLE 133 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 206 TABLE 134 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 207 TABLE 135 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 207 TABLE 136 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 207 TABLE 137 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 138 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 209 TABLE 139 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 209 TABLE 140 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 209 TABLE 141 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 210 TABLE 142 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 210 TABLE 143 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 210 TABLE 144 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 211 TABLE 145 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 211 TABLE 146 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 211 TABLE 147 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 212 TABLE 148 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 212 TABLE 149 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 150 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 151 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 214 TABLE 152 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 214 TABLE 153 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 214 TABLE 154 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 215 TABLE 155 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 215 TABLE 156 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 215 TABLE 157 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 216 TABLE 158 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 216 TABLE 159 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 216 TABLE 160 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 217 TABLE 161 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 217 TABLE 162 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 163 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 164 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 218 TABLE 165 UK: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 219 TABLE 166 UK: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 219 TABLE 167 UK: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 219 TABLE 168 UK: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 220 TABLE 169 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 220 TABLE 170 UK: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 220 TABLE 171 UK: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 221 TABLE 172 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 221 TABLE 173 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 221 TABLE 174 UK: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 222 TABLE 175 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 222 TABLE 176 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 177 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 223 TABLE 178 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 223 TABLE 179 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 224 TABLE 180 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 224 TABLE 181 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 224 TABLE 182 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225 TABLE 183 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 225 TABLE 184 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 225 TABLE 185 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 226 TABLE 186 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 226 TABLE 187 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 226 TABLE 188 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 227 TABLE 189 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 190 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 228 TABLE 191 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 228 TABLE 192 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 228 TABLE 193 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 229 TABLE 194 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 229 TABLE 195 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 229 TABLE 196 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 230 TABLE 197 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 230 TABLE 198 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 230 TABLE 199 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 231 TABLE 200 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 231 TABLE 201 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 231 TABLE 202 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 203 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 232 TABLE 204 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 233 TABLE 205 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 233 TABLE 206 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 233 TABLE 207 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 234 TABLE 208 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 234 TABLE 209 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 234 TABLE 210 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 235 TABLE 211 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 235 TABLE 212 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 235 TABLE 213 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 236 TABLE 214 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 215 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 216 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 217 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 239 TABLE 218 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 240 TABLE 219 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 240 TABLE 220 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 240 TABLE 221 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 241 TABLE 222 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 241 TABLE 223 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 241 TABLE 224 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 242 TABLE 225 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 242 TABLE 226 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 242 TABLE 227 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 243 TABLE 228 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 229 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 230 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 244 TABLE 231 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 245 TABLE 232 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 245 TABLE 233 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 245 TABLE 234 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 246 TABLE 235 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 246 TABLE 236 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 246 TABLE 237 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 247 TABLE 238 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 247 TABLE 239 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 247 TABLE 240 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 248 TABLE 241 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 248 TABLE 242 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 243 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 249 TABLE 244 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 249 TABLE 245 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 250 TABLE 246 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 250 TABLE 247 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 250 TABLE 248 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 251 TABLE 249 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 251 TABLE 250 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 251 TABLE 251 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 252 TABLE 252 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 252 TABLE 253 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 252 TABLE 254 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 253 TABLE 255 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 256 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 254 TABLE 257 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 254 TABLE 258 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 255 TABLE 259 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 255 TABLE 260 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 255 TABLE 261 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 256 TABLE 262 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 256 TABLE 263 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 256 TABLE 264 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 257 TABLE 265 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 257 TABLE 266 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 257 TABLE 267 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 258 TABLE 268 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 269 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 259 TABLE 270 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 259 TABLE 271 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 260 TABLE 272 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 260 TABLE 273 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 260 TABLE 274 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 261 TABLE 275 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 261 TABLE 276 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 261 TABLE 277 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 262 TABLE 278 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 262 TABLE 279 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 262 TABLE 280 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 263 TABLE 281 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 264 TABLE 282 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 283 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 264 TABLE 284 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 265 TABLE 285 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 265 TABLE 286 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 265 TABLE 287 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 266 TABLE 288 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 266 TABLE 289 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 266 TABLE 290 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 267 TABLE 291 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 267 TABLE 292 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 267 TABLE 293 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 268 TABLE 294 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 268 TABLE 295 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 296 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 269 TABLE 297 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 269 TABLE 298 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 270 TABLE 299 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 270 TABLE 300 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 270 TABLE 301 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 271 TABLE 302 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 271 TABLE 303 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 271 TABLE 304 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 272 TABLE 305 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 272 TABLE 306 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 272 TABLE 307 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 308 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 309 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 274 TABLE 310 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 274 TABLE 311 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 275 TABLE 312 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 275 TABLE 313 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 275 TABLE 314 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 276 TABLE 315 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 276 TABLE 316 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 276 TABLE 317 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 277 TABLE 318 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 277 TABLE 319 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 277 TABLE 320 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 278 TABLE 321 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 322 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 279 TABLE 323 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 279 TABLE 324 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 280 TABLE 325 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 280 TABLE 326 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION)SOFTWARE 280 TABLE 327 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 281 TABLE 328 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 281 TABLE 329 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 281 TABLE 330 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 282 TABLE 331 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 282 TABLE 332 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 282 TABLE 333 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 334 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 335 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 336 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 285 TABLE 337 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 285 TABLE 338 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 285 TABLE 339 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 286 TABLE 340 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 286 TABLE 341 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 286 TABLE 342 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 287 TABLE 343 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 287 TABLE 344 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 287 TABLE 345 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 288 TABLE 346 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 288 TABLE 347 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 288 TABLE 348 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 349 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 290 TABLE 350 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 290 TABLE 351 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 290 TABLE 352 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 291 TABLE 353 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 291 TABLE 354 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 291 TABLE 355 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 292 TABLE 356 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 292 TABLE 357 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 292 TABLE 358 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 293 TABLE 359 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 293 TABLE 360 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 293 TABLE 361 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 362 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2023–2030 (USD MILLION) 294 TABLE 363 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SERVICE TYPE, 2023–2030 (USD MILLION) 295 TABLE 364 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY MANAGED SERVICE TYPE, 2023–2030 (USD MILLION) 295 TABLE 365 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY PROFESSIONAL SERVICE TYPE, 2023–2030 (USD MILLION) 295 TABLE 366 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SOFTWARE TYPE, 2023–2030 (USD MILLION) 296 TABLE 367 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 296 TABLE 368 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY RESEARCH & DEVELOPMENT APPLICATION TYPE, 2023–2030 (USD MILLION) 296 TABLE 369 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY CLINICAL TRIAL TYPE, 2023–2030 (USD MILLION) 297 TABLE 370 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2023–2030 (USD MILLION) 297 TABLE 371 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMMERCIAL ANALYTICS APPLICATION TYPE, 2023–2030 (USD MILLION) 297 TABLE 372 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY SAFETY APPLICATION TYPE, 2023–2030 (USD MILLION) 298 TABLE 373 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2023–2030 (USD MILLION) 298 TABLE 374 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 300 TABLE 375 LIFE SCIENCE ANALYTICS MARKET: DEGREE OF COMPETITION 304 TABLE 376 LIFE SCIENCE ANALYTICS MARKET: REGION FOOTPRINT (25 COMPANIES) 308 TABLE 377 LIFE SCIENCE ANALYTICS MARKET: TYPE FOOTPRINT (25 COMPANIES) 309 TABLE 378 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT (25 COMPANIES) 310 TABLE 379 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT (25 COMPANIES) 311 TABLE 380 LIFE SCIENCE ANALYTICS MARKET: END USER FOOTPRINT (25 COMPANIES) 312 TABLE 381 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 315 TABLE 382 LIFE SCIENCE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES) 316 TABLE 383 LIFE SCIENCE ANALYTICS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 319 TABLE 384 LIFE SCIENCE ANALYTICS MARKET: DEALS, JANUARY 2022–MARCH 2025 320 TABLE 385 ORACLE: COMPANY OVERVIEW 323 TABLE 386 ORACLE: PRODUCTS & SERVICES OFFERED 324 TABLE 387 ORACLE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 326 TABLE 388 ORACLE: DEALS, JANUARY 2022–MARCH 2025 326 TABLE 389 MERATIVE: COMPANY OVERVIEW 329 TABLE 390 MERATIVE: PRODUCTS & SERVICES OFFERED 329 TABLE 391 MERATIVE: DEALS, JANUARY 2022–MARCH 2025 330 TABLE 392 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 330 TABLE 393 SAS INSTITUTE: COMPANY OVERVIEW 332 TABLE 394 SAS INSTITUTE: PRODUCTS & SERVICES OFFERED 333 TABLE 395 SAS INSTITUTE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 333 TABLE 396 SAS INSTITUTE: DEALS, JANUARY 2022–MARCH 2025 334 TABLE 397 ACCENTURE: COMPANY OVERVIEW 336 TABLE 398 ACCENTURE: PRODUCTS OFFERED 338 TABLE 399 ACCENTURE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 338 TABLE 400 ACCENTURE: DEALS, JANUARY 2022–MARCH 2025 339 TABLE 401 ACCENTURE: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 339 TABLE 402 IQVIA: COMPANY OVERVIEW 341 TABLE 403 IQVIA: PRODUCTS & SERVICES OFFERED 342 TABLE 404 IQVIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 344 TABLE 405 IQVIA: DEALS, JANUARY 2022–MARCH 2025 345 TABLE 406 IQVIA: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 345 TABLE 407 COGNIZANT: COMPANY OVERVIEW 347 TABLE 408 COGNIZANT: PRODUCTS & SERVICES OFFERED 348 TABLE 409 COGNIZANT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 350 TABLE 410 COGNIZANT: DEALS, JANUARY 2022–MARCH 2025 350 TABLE 411 WIPRO: COMPANY OVERVIEW 351 TABLE 412 WIPRO: PRODUCTS & SERVICES OFFERED 353 TABLE 413 WIPRO: DEALS, JANUARY 2022–MARCH 2025 354 TABLE 414 VERADIGM: COMPANY OVERVIEW 355 TABLE 415 VERADIGM: PRODUCTS & SERVICES OFFERED 356 TABLE 416 VERADIGM: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 357 TABLE 417 VERADIGM: DEALS, JANUARY 2022–MARCH 2025 357 TABLE 418 OPTUM: COMPANY OVERVIEW 358 TABLE 419 OPTUM: PRODUCTS & SERVICES OFFERED 359 TABLE 420 MICROSOFT: COMPANY OVERVIEW 360 TABLE 421 MICROSOFT: PRODUCTS & SERVICES OFFERED 361 TABLE 422 MICROSOFT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 362 TABLE 423 MICROSOFT: DEALS, JANUARY 2022–MARCH 2025 362 TABLE 424 MAXISIT: COMPANY OVERVIEW 363 TABLE 425 MAXISIT: PRODUCTS & SERVICES OFFERED 363 TABLE 426 MAXISIT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 364 TABLE 427 EXLSERVICE HOLDINGS: COMPANY OVERVIEW 365 TABLE 428 EXLSERVICE HOLDINGS: PRODUCTS & SERVICES OFFERED 366 TABLE 429 EXLSERVICE HOLDINGS: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 367 TABLE 430 EXLSERVICE HOLDINGS: DEALS, JANUARY 2022–MARCH 2025 367 TABLE 431 INOVALON: COMPANY OVERVIEW 368 TABLE 432 INOVALON: PRODUCTS & SERVICES OFFERED 369 TABLE 433 INOVALON: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 370 TABLE 434 INOVALON: DEALS, JANUARY 2022–MARCH 2025 370 TABLE 435 CITIUSTECH: COMPANY OVERVIEW 371 TABLE 436 CITIUSTECH: PRODUCTS & SERVICES OFFERED 371 TABLE 437 CITIUSTECH: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 372 TABLE 438 CITIUSTECH: DEALS, JANUARY 2022–MARCH 2025 373 TABLE 439 CITIUSTECH: EXPANSIONS, JANUARY 2022–MARCH 2025 373 TABLE 440 SAAMA: COMPANY OVERVIEW 374 TABLE 441 SAAMA: PRODUCTS & SERVICES OFFERED 374 TABLE 442 SAAMA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 375 TABLE 443 SAAMA: DEALS, JANUARY 2022–MARCH 2025 376 TABLE 444 SAAMA: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 376 TABLE 445 AXTRIA: COMPANY OVERVIEW 377 TABLE 446 AXTRIA: PRODUCTS & SERVICES OFFERED 377 TABLE 447 AXTRIA: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 378 TABLE 448 AXTRIA: DEALS, JANUARY 2022–MARCH 2025 378 TABLE 449 AXTRIA: EXPANSIONS, JANUARY 2022–MARCH 2025 378 TABLE 450 CLARIVATE: COMPANY OVERVIEW 379 TABLE 451 CLARIVATE: PRODUCTS & SERVICES OFFERED 381 TABLE 452 CLARIVATE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 382 TABLE 453 CLARIVATE: DEALS, JANUARY 2022–MARCH 2025 383 TABLE 454 THOUGHTSPHERE: COMPANY OVERVIEW 384 TABLE 455 THOUGHTSPHERE: PRODUCTS & SERVICES OFFERED 385 TABLE 456 THOUGHTSPOT: COMPANY OVERVIEW 386 TABLE 457 THOUGHTSPOT: PRODUCTS & SERVICES OFFERED 386 TABLE 458 THOUGHTSPOT: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 387 TABLE 459 THOUGHTSPOT: DEALS, JANUARY 2022–MARCH 2025 387 TABLE 460 SALESFORCE: COMPANY OVERVIEW 388 TABLE 461 SALESFORCE: PRODUCTS & SERVICES OFFERED 389 TABLE 462 SALESFORCE: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–MARCH 2025 390 TABLE 463 SALESFORCE: DEALS, JANUARY 2022–MARCH 2025 390 FIGURE 1 RESEARCH DESIGN 42 FIGURE 2 PRIMARY SOURCES 44 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 45 FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 46 FIGURE 5 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION 47 FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON LIFE SCIENCE ANALYTICS 48 FIGURE 7 LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 49 FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 50 FIGURE 9 TOP-DOWN APPROACH 50 FIGURE 10 DATA TRIANGULATION METHODOLOGY 51 FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 54 FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2025 VS. 2030 (USD MILLION) 55 FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 55 FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 56 FIGURE 15 LIFE SCIENCE ANALYTICS MARKET: REGIONAL SNAPSHOT 57 FIGURE 16 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET 58 FIGURE 17 NORTH AMERICA TO DOMINATE LIFE SCIENCE ANALYTICS MARKET THROUGHOUT FORECAST PERIOD 59 FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US HELD LARGEST MARKET SHARE IN NORTH AMERICA IN 2024 60 FIGURE 19 CHINA TO REGISTER HIGHEST CAGR IN GLOBAL MARKET DURING FORECAST PERIOD 61 FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 61 FIGURE 21 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62 FIGURE 22 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 (OR NEAREST YEAR) 64 FIGURE 23 LIFE SCIENCE ANALYTICS MARKET ECOSYSTEM 80 FIGURE 24 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS 82 FIGURE 25 LIFE SCIENCE ANALYTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 83 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 86 FIGURE 27 KEY BUYING CRITERIA FOR END USERS 87 FIGURE 28 REVENUE SHIFT IN LIFE SCIENCE ANALYTICS MARKET 98 FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANTS FOR LIFE SCIENCE ANALYTICS PATENTS, JANUARY 2011–MARCH 2025 99 FIGURE 30 MAJOR PATENTS FOR LIFE SCIENCE ANALYTICS, JANUARY 2011– MARCH 2025 100 FIGURE 31 FUNDING OF PLAYERS IN LIFE SCIENCE ANALYTICS MARKET 106 FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI, BY INDUSTRY 109 FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 112 FIGURE 34 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT 187 FIGURE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT 238 FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET, 2020–2024 303 FIGURE 37 LIFE SCIENCE ANALYTICS MARKET: MARKET SHARE ANALYSIS (2024) 304 FIGURE 38 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 306 FIGURE 39 LIFE SCIENCE ANALYTICS MARKET: COMPANY FOOTPRINT (25 COMPANIES) 307 FIGURE 40 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 314 FIGURE 41 EV/EBITDA OF KEY VENDORS 318 FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICS VENDORS 318 FIGURE 43 ORACLE: COMPANY SNAPSHOT 324 FIGURE 44 ACCENTURE: COMPANY SNAPSHOT 337 FIGURE 45 IQVIA: COMPANY SNAPSHOT 342 FIGURE 46 COGNIZANT: COMPANY SNAPSHOT 348 FIGURE 47 WIPRO: COMPANY SNAPSHOT 352 FIGURE 48 VERADIGM: COMPANY SNAPSHOT 356 FIGURE 49 UNITED HEALTH GROUP: COMPANY SNAPSHOT 358 FIGURE 50 MICROSOFT: COMPANY SNAPSHOT 361 FIGURE 51 EXLSERVICE HOLDINGS: COMPANY SNAPSHOT 366 FIGURE 52 CLARIVATE: COMPANY SNAPSHOT 380 FIGURE 53 SALESFORCE: COMPANY SNAPSHOT 389